Evaluation of effect of cooled haemodialysis on cognition in patients with end-stage kidney disease (ECHECKED) feasibility randomised controlled trial results
2024

Effect of Cooled Haemodialysis on Cognition in Kidney Disease Patients

Sample size: 43 publication 10 minutes Evidence: moderate

Author Information

Author(s): Indranil Dasgupta, Aghogho Odudu, Jyoti Baharani, Niall Fergusson, Helen Griffiths, John Harrison, Awais Hameed, Paul Maruff, Louise Ryan, Neil Thomas, Gavin Woodhall, George Tadros

Primary Institution: Renal Unit, Heartlands Hospital, Birmingham, UK

Hypothesis

Does cooled dialysate improve cognitive function in patients undergoing haemodialysis?

Conclusion

Cooled dialysate did not show a significant difference in cognitive function compared to standard temperature dialysis over 12 months.

Supporting Evidence

  • Of 334 patients screened, 160 were eligible for the study.
  • 61 patients consented, and 43 were randomised to either standard care or cooled dialysate.
  • 27 patients completed the trial, with a significant attrition rate due to various factors including the pandemic.

Takeaway

This study looked at whether cooler dialysis water helps people with kidney disease think better, but it didn't find a big difference.

Methodology

A double-blinded, randomised controlled feasibility trial comparing standard care and cooled dialysate in haemodialysis patients.

Potential Biases

Potential bias due to the requirement of English fluency for participation.

Limitations

High attrition rate due to COVID-19 and challenges in recruitment related to non-dialysis day visits.

Participant Demographics

Participants were predominantly older adults, with a mix of genders and ethnicities.

Statistical Information

P-Value

0.755

Confidence Interval

(-2.8–3.0)

Statistical Significance

p=0.755

Digital Object Identifier (DOI)

10.1186/s12882-024-03883-6

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication